Bush Jennifer sold $94K of ARTV
Bush Jennifer (COO, CLO, Compliance Officer) sold 8,391 shares of Artiva Biotherapeutics, Inc. (ARTV) at $11.16 on 2026-09-03.
How this was made
The 30-second read
Why it matters
The disclosed sale is the first public report of this transaction, providing new data for investors.
Market read
First‑report insider sale adds modest new information; limited trading relevance.
What to watch
The insider still holds a substantial position, indicating continued confidence.
Background
Form 4 filing discloses insider transactions required by SEC regulations.
Ticker impact
COO Jennifer Bush sold 8,391 shares for $93,606, reducing her stake to 329,529 shares.
modest short‑term price pressure
The sale size is modest relative to market cap, but the insider remains a large holder, limiting downside risk.
Market effects
Biotech sector may see slight caution after insider sell.
US biotech equities could experience minor ripple.
Limited global impact.
Counterpoint
The sale could be routine liquidity for the executive, not a negative signal.
Key entities
- CompanyArtiva Biotherapeutics, Inc.
US‑listed biotech company (ticker ARTV).
- ExecutiveJennifer Bush
Chief Operating Officer, Chief Legal Officer, and Compliance Officer of Artiva.